FMC
FMC Corporation NYSE Listed Mar 17, 1980$13.68
Mkt Cap $1.7B
52w Low $12.17
4.6% of range
52w High $44.78
50d MA $15.43
200d MA $22.19
P/E (TTM)
-0.8x
EV/EBITDA
-63.2x
P/B
0.9x
Debt/Equity
2.0x
ROE
-83.1%
P/FCF
-9.8x
RSI (14)
—
ATR (14)
—
Beta
0.52
50d MA
$15.43
200d MA
$22.19
Avg Volume
4.0M
FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that include insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. FMC Corporation was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
2929 Walnut Street · Philadelphia, PA 19104 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | AMC | -0.39 | -0.23 | +41.0% | 14.65 | +10.2% | +5.0% | +1.2% | -0.6% | +1.5% | +1.0% | — |
| Feb 4, 2026 | AMC | 1.21 | 1.20 | -0.8% | 16.99 | -11.2% | -19.5% | -13.1% | -9.4% | -5.8% | -5.5% | — |
| Oct 29, 2025 | AMC | 0.85 | 0.89 | +4.7% | 29.04 | -24.7% | -46.5% | -47.8% | -51.1% | -53.8% | -54.0% | — |
| Jul 30, 2025 | AMC | 0.59 | 0.69 | +16.9% | 41.33 | +2.8% | -5.5% | -8.0% | -8.8% | -8.4% | -11.2% | — |
| Apr 30, 2025 | AMC | 0.08 | 0.18 | +125.0% | 41.92 | -3.2% | -8.3% | -9.9% | -14.3% | -15.0% | -16.6% | — |
| Feb 4, 2025 | AMC | 1.65 | 1.79 | +8.5% | 54.04 | -33.5% | -33.5% | -34.0% | -36.1% | -35.0% | -32.5% | — |
| Oct 29, 2024 | AMC | 0.49 | 0.69 | +40.8% | 60.18 | +5.5% | +10.7% | +8.0% | +4.9% | +5.4% | +5.7% | — |
| Jul 31, 2024 | AMC | 0.50 | 0.63 | +26.0% | 58.36 | +8.6% | +10.2% | +6.6% | +5.7% | +4.9% | +5.0% | — |
| May 6, 2024 | AMC | 0.35 | 0.36 | +2.9% | 60.98 | +2.0% | +9.5% | +6.3% | +9.9% | +10.7% | +9.4% | — |
| Feb 5, 2024 | AMC | 1.09 | 1.07 | -1.8% | 60.42 | -13.8% | -11.5% | -9.5% | -13.9% | -14.3% | -11.3% | — |
| Oct 30, 2023 | AMC | 0.45 | 0.44 | -2.2% | 57.96 | -3.1% | -8.2% | -13.7% | -5.6% | -4.4% | -4.4% | — |
| Aug 2, 2023 | AMC | 0.59 | 0.50 | -15.3% | 92.82 | -1.4% | -2.0% | -1.4% | -1.9% | -4.5% | -6.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | JP Morgan | Maintains | Neutral → Neutral | — | $15.38 | $15.21 | -1.1% | -3.6% | -5.3% | -3.3% | -3.8% | -11.1% |
| May 1 | Citigroup | Maintains | Neutral → Neutral | — | $15.38 | $15.21 | -1.1% | -3.6% | -5.3% | -3.3% | -3.8% | -11.1% |
| May 1 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $15.38 | $15.21 | -1.1% | -3.6% | -5.3% | -3.3% | -3.8% | -11.1% |
| Apr 24 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $14.45 | $14.56 | +0.8% | +3.0% | +7.7% | +5.6% | +1.4% | +6.4% |
| Apr 22 | Vertical Research | Downgrade | Hold → Sell | $14 | $15.87 | $15.72 | -0.9% | -7.4% | -8.9% | -6.2% | -2.0% | -3.8% |
| Apr 21 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $17.35 | $17.00 | -2.0% | -8.5% | -15.3% | -16.7% | -14.2% | -10.3% |
| Apr 14 | Goldman Sachs | Maintains | Buy → Buy | — | $18.07 | $18.15 | +0.4% | -3.6% | -3.6% | -2.7% | -5.0% | -4.0% |
| Apr 9 | UBS | Maintains | Neutral → Neutral | — | $17.84 | $17.92 | +0.4% | -3.5% | -2.2% | +1.3% | -2.4% | -2.4% |
| Feb 17 | Mizuho | Maintains | Outperform → Outperform | — | $14.34 | $14.14 | -1.4% | +1.0% | +1.0% | +3.6% | +2.0% | -4.7% |
| Feb 9 | Citigroup | Maintains | Neutral → Neutral | — | $14.76 | $14.78 | +0.1% | +4.3% | +8.5% | +8.7% | -1.6% | -2.8% |
| Feb 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $13.67 | $13.58 | -0.7% | +8.0% | +12.6% | +17.1% | +17.4% | +6.3% |
| Feb 6 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $13.67 | $13.58 | -0.7% | +8.0% | +12.6% | +17.1% | +17.4% | +6.3% |
| Jan 21 | Citigroup | Maintains | Neutral → Neutral | — | $15.39 | $15.66 | +1.8% | +3.4% | +4.1% | +5.8% | +4.8% | +4.5% |
| Jan 16 | Mizuho | Maintains | Outperform → Outperform | — | $15.48 | $15.15 | -2.1% | -0.8% | -0.6% | +2.8% | +3.5% | +5.2% |
| Jan 12 | UBS | Maintains | Neutral → Neutral | — | $15.20 | $15.20 | +0.0% | -0.3% | +0.7% | -0.4% | +1.8% | +1.0% |
| Dec 18 | Citigroup | Maintains | Neutral → Neutral | — | $13.78 | $13.83 | +0.4% | -1.1% | -3.3% | -4.4% | -4.7% | -3.3% |
| Dec 15 | Mizuho | Maintains | Outperform → Outperform | — | $13.91 | $14.03 | +0.9% | -5.7% | -5.4% | -0.9% | -2.0% | -4.2% |
| Dec 9 | Barclays | Downgrade | Equal Weight → Underweight | — | $13.10 | $12.88 | -1.7% | +2.1% | +4.0% | +4.3% | +6.2% | +0.2% |
| Nov 17 | JP Morgan | Maintains | Neutral → Neutral | — | $13.90 | $13.69 | -1.5% | -6.8% | -7.8% | -8.7% | -12.4% | -8.3% |
| Nov 13 | Barclays | Maintains | Equal Weight → Equal Weight | — | $13.84 | $13.79 | -0.4% | -1.4% | +0.4% | -6.4% | -7.4% | -8.3% |
| Nov 3 | Goldman Sachs | Maintains | Buy → Buy | — | $15.17 | $15.02 | -1.0% | -6.5% | -11.6% | -11.9% | -14.5% | -7.8% |
| Nov 3 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $15.17 | $15.02 | -1.0% | -6.5% | -11.6% | -11.9% | -14.5% | -7.8% |
| Oct 31 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $15.53 | $15.01 | -3.3% | -2.3% | -8.6% | -13.7% | -14.0% | -16.5% |
| Oct 31 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $15.53 | $15.01 | -3.3% | -2.3% | -8.6% | -13.7% | -14.0% | -16.5% |
| Oct 31 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $15.53 | $15.01 | -3.3% | -2.3% | -8.6% | -13.7% | -14.0% | -16.5% |
| Oct 31 | Citigroup | Maintains | Neutral → Neutral | — | $15.53 | $15.01 | -3.3% | -2.3% | -8.6% | -13.7% | -14.0% | -16.5% |
| Oct 31 | UBS | Maintains | Neutral → Neutral | — | $15.53 | $15.01 | -3.3% | -2.3% | -8.6% | -13.7% | -14.0% | -16.5% |
| Oct 30 | Barclays | Downgrade | Overweight → Equal Weight | — | $29.04 | $21.88 | -24.7% | -46.5% | -47.8% | -51.1% | -53.8% | -54.0% |
| Oct 22 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $29.95 | $29.62 | -1.1% | -1.0% | +1.2% | +1.7% | +2.3% | +2.0% |
| Oct 22 | Goldman Sachs | Maintains | Buy → Buy | — | $29.95 | $29.62 | -1.1% | -1.0% | +1.2% | +1.7% | +2.3% | +2.0% |
| Oct 16 | Wells Fargo | Maintains | Overweight → Overweight | — | $30.09 | $30.31 | +0.7% | -0.4% | -2.3% | -1.9% | -0.5% | -1.4% |
| Oct 14 | BofA Securities | Upgrade | Underperform → Neutral | — | $29.54 | $29.27 | -0.9% | +2.9% | +1.9% | +1.5% | -0.5% | -0.0% |
| Oct 9 | Mizuho | Maintains | Outperform → Outperform | — | $30.34 | $30.84 | +1.6% | -1.5% | -4.2% | -2.6% | +0.2% | -0.8% |
| Oct 6 | UBS | Maintains | Neutral → Neutral | — | $32.24 | $32.00 | -0.7% | -2.9% | -3.5% | -5.9% | -7.3% | -9.8% |
| Oct 6 | Citigroup | Maintains | Neutral → Neutral | — | $32.24 | $32.00 | -0.7% | -2.9% | -3.5% | -5.9% | -7.3% | -9.8% |
| Aug 13 | Barclays | Maintains | Overweight → Overweight | — | $35.15 | $35.41 | +0.7% | +6.8% | +6.1% | +6.6% | +8.0% | +9.8% |
| Aug 1 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $39.04 | $38.71 | -0.8% | -2.6% | -3.4% | -3.1% | -6.0% | -6.5% |
| Aug 1 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $39.04 | $38.71 | -0.8% | -2.6% | -3.4% | -3.1% | -6.0% | -6.5% |
| Jul 31 | UBS | Maintains | Neutral → Neutral | — | $41.33 | $42.47 | +2.8% | -5.5% | -8.0% | -8.8% | -8.4% | -11.2% |
| Jul 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $42.38 | $42.44 | +0.1% | -0.8% | -2.4% | -0.2% | -0.3% | -0.8% |
| Jul 10 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $43.63 | $43.27 | -0.8% | -2.2% | -2.9% | -3.6% | -5.2% | -3.0% |
| Jul 9 | UBS | Maintains | Neutral → Neutral | — | $43.30 | $43.71 | +0.9% | +0.8% | -1.5% | -2.1% | -2.9% | -4.5% |
| Jul 7 | Barclays | Maintains | Overweight → Overweight | — | $44.23 | $43.77 | -1.0% | -2.4% | -2.1% | -1.4% | -3.5% | -4.2% |
| Jun 23 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $41.07 | $42.21 | +2.8% | +4.4% | +3.8% | +2.5% | +5.0% | +4.5% |
| May 2 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $38.45 | $38.96 | +1.3% | -1.7% | -6.6% | -7.3% | -9.0% | -4.8% |
| May 1 | UBS | Maintains | Neutral → Neutral | — | $41.92 | $40.58 | -3.2% | -8.3% | -9.9% | -14.3% | -15.0% | -16.6% |
| Apr 21 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $37.84 | $37.63 | -0.6% | +0.6% | +4.0% | +3.9% | +7.8% | +8.8% |
| Apr 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $37.10 | $37.75 | +1.8% | +1.3% | +0.8% | +0.4% | +2.0% | +2.6% |
| Mar 5 | Seaport Global | Maintains | Buy → Buy | — | $36.60 | $37.29 | +1.9% | +7.8% | +10.0% | +12.8% | +13.6% | +13.1% |
| Feb 18 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $36.62 | $36.78 | +0.4% | +3.8% | +2.8% | +4.3% | +4.5% | +3.7% |
No insider trades available.
8-K
FMC Corporation -- 8-K Filing
FMC Corporation's Q1 2026 revenue declined 4% to $762 million excluding India, while the company swung to a $2.25 per-share loss, signaling operational challenges despite divesting India operations.
Apr 29
8-K · 5.02
!!! Very High
FMC Corporation -- 8-K 5.02: Executive Change
FMC Corporation's board has lost a long-serving director with the passing of Dirk A. Kempthorne, who served since 2009, potentially affecting board composition and governance.
Apr 29
8-K · 1.01
! Medium
FMC Corporation -- 8-K 1.01: Financing / Debt Agreement
FMC Corporation amended its debt covenants, relaxing leverage and interest coverage ratios while introducing a 3.50x maximum secured leverage ratio, providing greater financial flexibility for the industrial company.
Apr 20
8-K
FMC Corporation -- 8-K Filing
FMC Corporation's board is exploring strategic alternatives including a potential sale, signaling management believes the company could unlock greater shareholder value through a transaction or restructuring.
Feb 4
Data updated apr 25, 2026 9:32am
· Source: massive.com